Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Small Cell Lung Carcinoma × PM 01183 × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 19 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

trilaciclib 1 rovalpituzumab tesirine 1 epigallocatechin gallate 1 dabrafenib 1 PM 01183 1 BID protein, human 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04291937 2020-06-19

A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA

Jazz Pharmaceuticals

Approved for marketing

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡